Thomas Malley Net Worth - Insider Trades and Bio as of Jun 5, 2026

KURAKura Oncology, Inc.SEC CIK: 0001403322

Estimated Net Worth

$6.65 Million

Last Updated: May 19, 2026 11:36 PM EST

Transaction Summary

Total Transactions77

Buy-Sell Ratio10.00

Buy Transactions10

Sell Transactions1

Transaction Volume

Total Volume$1.08M

Net Volume$9.17M

Buy Volume$5.12M

Sell Volume-$4.04M

Trade Analysis

AVG Trade Size$5.45K

Largest Trade$1.75M

Most Active MonthJun

Most Active Year2015

Trading Sentiment

OverallBullish

Recent TradeNeutral

Last 90 Days0 Trades

ConvictionNone

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Thomas Malley has an estimated net worth of $6.65 Million. This is based on reported shares across multiple companies, which include BeiGene, Ltd., Cougar Biotechnology, Inc., Kiniksa Pharmaceuticals International, plc, Kura Oncology, Inc., PUMA BIOTECHNOLOGY, INC., OvaScience, Inc., and SYNAGEVA BIOPHARMA CORP.

2025 was Thomas Malley's most active year for acquiring shares with 11 total transactions. Thomas Malley's most active month to acquire stocks was the month of May. 2025 was Thomas Malley's most active year for disposing of shares, totalling 11 transactions. Thomas Malley's most active month to dispose stocks was the month of May. 2015 saw Thomas Malley paying a total of $2,318,982.07 for 135,755 shares, this is the most they've acquired in one year. In 2025 Thomas Malley cashed out on 358,711 shares for a total of $5,859,815.05, their largest year based on trade value.

Holdings & Transactions

KURAkura oncology, inc.

Updated: Mar 20, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	20.00K	$3.12	$31.20K	Mar 20, 2026	149.56K	Options	—	Mar 18	View
From 4	—	28.50K	—	—	Jun 06, 2025	28.50K	Grant	—	Jun 05	View
From 4	—	26.00K	—	—	Jun 07, 2024	26.00K	Grant	—	Jun 05	View
From 4	0.56	50.00K	$11.50	$575.00K	Jun 21, 2023	139.56K	Purchase	—	Jun 16	View
From 4	—	26.00K	—	—	Jun 02, 2023	26.00K	Grant	—	May 31	View
From 4	—	23.00K	—	—	Jun 23, 2022	23.00K	Grant	—	Jun 21	View
From 4	—	23.00K	—	—	Jun 23, 2021	23.00K	Grant	—	Jun 22	View
From 4	—	23.00K	—	—	Jun 26, 2020	23.00K	Grant	—	Jun 24	View
From 4	—	13.00K	—	—	Jun 27, 2019	13.00K	Grant	—	Jun 25	View
From 4	—	13.00K	—	—	Jun 08, 2018	13.00K	Grant	—	Jun 07	View
From 4	—	10.00K	—	—	Jun 12, 2017	10.00K	Grant	—	Jun 09	View
From 4	—	10.00K	—	—	May 13, 2016	10.00K	Grant	—	May 12	View
From 4	1.26	50.00K	$8.00	$400.00K	Dec 17, 2015	89.56K	Purchase	—	Nov 10	View
From 4	—	30.00K	—	—	Oct 14, 2015	30.00K	Grant	—	Oct 13	View
From 3	—	—	—	—	Oct 14, 2015	39.56K	—	—	—	View

KNSAkiniksa pharmaceuticals international, plc

Updated: Aug 14, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.93	177.77K	$21.59	-$4.04M	Aug 14, 2025	84.51K	Sale	—	Aug 12 - 14	View
From 4	1.56	19.60K	—	—	Jun 05, 2025	104.11K	Options	—	Jun 03 - 05	View
From 4	2.37	22.21K	—	—	Jun 07, 2024	103.55K	Options	—	Jun 05 - 06	View
From 4	—	—	—	—	Jul 03, 2023	76.97K	Options	—	Jun 29	View
From 4	—	30.61K	—	—	Jun 08, 2023	30.61K	Grant	—	Jun 06	View
From 4	—	35.00K	—	—	Jun 30, 2022	35.00K	Grant	—	Jun 29	View
From 4	—	33.24K	—	—	Jun 30, 2021	33.24K	Grant	—	Jun 29	View
From 4	—	18.76K	—	—	Jul 02, 2020	18.76K	Grant	—	Jun 30	View
From 4	—	18.76K	—	—	May 30, 2019	18.76K	Grant	—	May 29	View
From 4	—	—	—	—	May 29, 2018	71.97K	Options	—	May 29	View
From 3	—	—	—	—	May 23, 2018	—	—	—	—	View

BGNEbeigene, ltd.

Updated: Jun 20, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.18	39.90K	—	—	Jun 20, 2023	103.67K	Grant	—	Jun 15	View
From 4	3.01	51.34K	—	—	Jun 24, 2022	98.42K	Grant	—	Jun 22	View
From 4	2.73	25.30K	—	—	Jun 21, 2021	64.58K	Grant	—	Jun 16	View
From 4	—	45.38K	—	—	Jun 19, 2020	45.38K	Grant	—	Jun 17	View
From 4	—	64.61K	—	—	Jun 07, 2019	64.61K	Grant	—	Jun 05	View
From 4	—	26.73K	—	—	Jun 08, 2018	56.73K	Grant	—	Jun 06	View
From 4	—	169.99K	—	—	Jun 06, 2017	169.99K	Grant	—	Jun 02	View
From 4	—	30.00K	$32.00	$960.00K	Nov 28, 2016	30.00K	Purchase	—	Nov 23	View
From 3	—	—	—	—	Feb 02, 2016	—	—	—	—	View

TPSTovascience, inc.

Updated: Jul 05, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.04	7.87K	—	—	Jul 05, 2017	204.98K	Grant	—	Jun 13	View
From 4	0.04	7.08K	—	—	Apr 04, 2017	197.11K	Grant	—	Mar 31	View
From 4	0.05	8.66K	$1.53	$13.25K	Jan 04, 2017	190.02K	Grant	—	Dec 30	View
From 4	0.01	1.85K	—	—	Oct 04, 2016	181.36K	Grant	—	Sep 30	View
From 4	0.01	2.54K	—	—	Jul 05, 2016	179.51K	Grant	—	Jun 30	View
From 4	—	12.00K	—	—	Jun 06, 2016	12.00K	Grant	—	Jun 02	View
From 4	0.39	50.00K	$7.00	$350.00K	Jun 03, 2016	176.97K	Grant	—	Jun 01	View
From 4	0.01	1.40K	—	—	Apr 04, 2016	126.97K	Grant	—	Mar 31	View
From 4	0.01	1.36K	—	—	Jan 05, 2016	125.57K	Grant	—	Dec 31	View
From 4	0.01	1.56K	—	—	Oct 02, 2015	124.22K	Grant	—	Sep 30	View
From 4	0.00	458.00	$28.93	$13.25K	Jul 02, 2015	122.66K	Grant	—	Jun 30	View
From 4	—	12.00K	—	—	Jun 08, 2015	12.00K	Grant	—	Jun 04	View
From 4	0.04	5.00K	$28.50	$142.50K	Apr 09, 2015	122.20K	Purchase	—	Apr 08	View
From 4	0.00	381.00	$34.73	$13.23K	Apr 02, 2015	117.20K	Grant	—	Mar 31	View
From 4	0.43	35.00K	$50.00	$1.75M	Jan 15, 2015	116.82K	Purchase	—	Jan 13	View
From 4	—	6.50K	—	—	Jun 17, 2014	6.50K	Grant	—	Jun 13	View
From 4	—	4.45K	—	—	Jun 11, 2013	4.45K	Grant	—	Jun 07	View
From 4	1.57	50.00K	$9.00	$450.00K	Mar 20, 2013	81.82K	Purchase	—	Mar 18	View
From 4	—	13.10K	—	—	Oct 26, 2012	13.10K	Grant	—	Oct 24	View
From 3	—	—	—	—	Oct 26, 2012	31.82K	—	—	—	View

synageva biopharma corp

Updated: Jun 23, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	91.83K	—	—	Jun 23, 2015	—	Disposition	—	Jun 22	View
From 4	—	7.50K	—	—	Jun 05, 2014	7.50K	Grant	—	Jun 04	View
From 4	—	7.50K	—	—	Jun 10, 2013	7.50K	Grant	—	Jun 06	View
From 4	—	7.50K	—	—	Jun 29, 2012	7.50K	Grant	—	Jun 27	View
From 4/A	—	15.00K	—	—	Jan 11, 2012	15.00K	Grant	—	Dec 20	View
From 4	-0.50	15.00K	—	—	Dec 21, 2011	61.90K	Grant	—	Dec 20	View
From 4	—	—	$1.58	$20.89K	Dec 13, 2011	54.38K	Options	—	Dec 12	View
From 3	—	—	—	—	Nov 14, 2011	33.70K	—	—	—	View

PBYIpuma biotechnology, inc.

Updated: Dec 16, 2014VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	10.00K	—	—	Dec 16, 2014	10.00K	Grant	—	Dec 15	View
From 4	—	10.00K	—	—	Dec 20, 2013	10.00K	Grant	—	Dec 19	View
From 4	0.07	10.00K	$16.00	$160.00K	Oct 25, 2012	156.55K	Purchase	—	Oct 24	View
From 4	—	20.00K	—	—	Oct 22, 2012	20.00K	Grant	—	Oct 18	View
From 4	0.07	10.03K	$12.50	$125.40K	Jun 13, 2012	146.55K	Purchase	—	Jun 11	View
From 4	0.08	9.97K	$12.50	$124.60K	Jun 11, 2012	136.52K	Purchase	—	Jun 07 - 08	View
From 4	—	50.00K	—	—	Feb 14, 2012	50.00K	Grant	—	Feb 13	View
From 4	—	126.55K	$3.75	$474.57K	Nov 21, 2011	126.55K	Grant	—	Nov 18	View
From 3	—	—	—	—	Oct 11, 2011	—	—	—	—	View

cougar biotechnology, inc.

Updated: Jul 07, 2009

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	59.92K	$29.93	-$1.57M	Jul 07, 2009	—	Disposition	—	Jul 03	View
From 4	—	10.00K	—	—	Jun 19, 2008	59.92K	Grant	—	Jun 17	View
From 4	—	19.92K	$21.75	$433.22K	Jul 20, 2007	49.92K	Purchase	—	Jul 17 - 19	View
From 4	—	30.00K	—	—	Jun 15, 2007	30.00K	Grant	—	Jun 12	View
From 3	—	—	—	—	Jun 15, 2007	—	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions